Sio Capital Management as of June 30, 2020
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 77 positions in its portfolio as reported in the June 2020 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Coherus Biosciences (CHRS) | 5.9 | $20M | 1.1M | 17.86 | |
Spdr Gold Shares Gold Shs (GLD) | 5.9 | $20M | 121k | 167.37 | |
McKesson Corporation (MCK) | 4.4 | $15M | 97k | 153.42 | |
Teva Pharmaceutical Industries Sponsored Ads (TEVA) | 3.5 | $12M | 963k | 12.33 | |
Gw Pharmaceuticals Ads | 3.4 | $12M | 95k | 122.72 | |
AmerisourceBergen (COR) | 3.0 | $10M | 101k | 100.77 | |
Molina Healthcare (MOH) | 3.0 | $10M | 57k | 177.99 | |
Hill-Rom Holdings | 2.9 | $9.9M | 90k | 109.78 | |
Merck & Co (MRK) | 2.6 | $8.8M | 114k | 77.33 | |
Mersana Therapeutics (MRSN) | 2.5 | $8.7M | 372k | 23.40 | |
R1 Rcm | 2.5 | $8.5M | 763k | 11.15 | |
Anthem (ELV) | 2.4 | $8.4M | 32k | 262.99 | |
Cymabay Therapeutics | 2.3 | $8.0M | 2.3M | 3.49 | |
Soliton | 2.3 | $8.0M | 1.0M | 7.78 | |
Hca Holdings (HCA) | 2.3 | $7.9M | 82k | 97.06 | |
United Therapeutics Corporation (UTHR) | 2.3 | $7.9M | 65k | 120.99 | |
Eli Lilly & Co. (LLY) | 2.2 | $7.5M | 46k | 164.18 | |
Biogen Idec (BIIB) | 2.2 | $7.4M | 28k | 267.54 | |
Mesoblast Spons Adr Put Option | 2.1 | $7.3M | 641k | 11.39 | |
Cardinal Health (CAH) | 2.0 | $7.0M | 134k | 52.19 | |
Bristol-myers Squibb Right | 1.8 | $6.2M | 1.7M | 3.58 | |
Orthofix Medical (OFIX) | 1.8 | $6.1M | 192k | 32.00 | |
Arena Pharmaceuticals Com New | 1.7 | $6.0M | 95k | 62.95 | |
OraSure Technologies (OSUR) | 1.6 | $5.3M | 460k | 11.63 | |
Walgreen Boots Alliance (WBA) | 1.5 | $5.3M | 124k | 42.39 | |
Curis Com New | 1.5 | $5.2M | 4.3M | 1.21 | |
Viking Therapeutics (VKTX) | 1.5 | $5.1M | 710k | 7.21 | |
Radius Health Com New | 1.4 | $4.9M | 362k | 13.63 | |
Cel-sci Corp Com Par New Put Option (CVM) | 1.4 | $4.9M | 331k | 14.92 | |
Affimed Therapeutics B V | 1.3 | $4.3M | 933k | 4.61 | |
Chardan Healthcr Acqstn 2 | 1.2 | $4.2M | 400k | 10.50 | |
Ardelyx (ARDX) | 1.2 | $4.2M | 602k | 6.92 | |
Larimar Therapeutics (LRMR) | 1.2 | $4.1M | 318k | 12.85 | |
Quanterix Ord (QTRX) | 1.2 | $4.0M | 146k | 27.39 | |
Boston Scientific Corporation (BSX) | 1.1 | $3.9M | 112k | 35.11 | |
Immunovant (IMVT) | 1.1 | $3.7M | 153k | 24.35 | |
I-mab Sponsored Ads (IMAB) | 1.0 | $3.5M | 118k | 29.93 | |
Esperion Therapeutics (ESPR) | 0.9 | $3.2M | 62k | 51.31 | |
Leap Therapeutics | 0.9 | $3.1M | 1.5M | 2.09 | |
Vapotherm | 0.9 | $3.1M | 76k | 40.99 | |
Syros Pharmaceuticals | 0.8 | $2.9M | 273k | 10.66 | |
Viewray (VRAYQ) | 0.8 | $2.9M | 1.3M | 2.24 | |
Actinium Pharmaceuticals | 0.8 | $2.9M | 8.1M | 0.35 | |
Aslan Pharmaceuticals Ads | 0.8 | $2.8M | 1.4M | 2.00 | |
Cerecor | 0.8 | $2.6M | 1.0M | 2.60 | |
Lifesci Acquisition Corp Unit 03/31/2025 | 0.7 | $2.3M | 210k | 11.00 | |
RadNet (RDNT) | 0.6 | $2.1M | 135k | 15.87 | |
Zynerba Pharmaceuticals Put Option | 0.6 | $2.1M | 629k | 3.37 | |
Aeglea Biotherapeutics | 0.6 | $2.0M | 211k | 9.25 | |
Inogen (INGN) | 0.6 | $1.9M | 54k | 35.52 | |
Dyadic International (DYAI) | 0.5 | $1.8M | 209k | 8.66 | |
Vanda Pharmaceuticals (VNDA) | 0.5 | $1.6M | 144k | 11.44 | |
Neubase Therapeutics Ord | 0.5 | $1.6M | 179k | 8.78 | |
Precision Biosciences Ord | 0.4 | $1.5M | 185k | 8.33 | |
Anika Therapeutics (ANIK) | 0.4 | $1.4M | 36k | 37.72 | |
Harrow Health (HROW) | 0.4 | $1.2M | 239k | 5.21 | |
Morphic Hldg (MORF) | 0.4 | $1.2M | 45k | 27.06 | |
Catalyst Biosciences Com New | 0.3 | $1.2M | 199k | 5.87 | |
Ayala Pharmaceuticals Incorporated | 0.3 | $1.2M | 115k | 10.10 | |
Sutro Biopharma (STRO) | 0.3 | $1.2M | 148k | 7.76 | |
Kodiak Sciences (KOD) | 0.3 | $1.1M | 21k | 54.14 | |
Progyny (PGNY) | 0.3 | $1.0M | 39k | 25.82 | |
Minerva Neurosciences Put Option | 0.3 | $878k | 243k | 3.61 | |
Aravive | 0.2 | $796k | 68k | 11.64 | |
Bionano Genomics | 0.2 | $789k | 1.5M | 0.51 | |
Ideaya Biosciences (IDYA) | 0.2 | $782k | 55k | 14.22 | |
Trillium Therapeutics Com New | 0.2 | $702k | 87k | 8.09 | |
Kura Oncology (KURA) | 0.2 | $696k | 43k | 16.31 | |
Neoleukin Therapeutics | 0.2 | $636k | 38k | 16.60 | |
Atreca Cl A Com (BCEL) | 0.1 | $458k | 22k | 21.28 | |
Rapt Therapeutics (RAPT) | 0.1 | $415k | 14k | 29.02 | |
Kadmon Hldgs | 0.1 | $269k | 53k | 5.12 | |
Seres Therapeutics Put Option (MCRB) | 0.1 | $264k | 56k | 4.76 | |
Cellectar Biosciences Com Par | 0.1 | $243k | 190k | 1.28 | |
Mei Pharma Com New | 0.1 | $198k | 48k | 4.12 | |
Bellicum Pharmaceuticals Com New | 0.0 | $58k | 7.8k | 7.48 | |
Fusion Pharmaceuticals (FUSN) | 0.0 | $52k | 3.0k | 17.33 |